Abstract
On January 9th, 2021, the Laboratory Medicine & Pathobiology Students Union (LMPSU) hosted their annual scientific conference online, focusing on the theme: “COVID-19: A viral phenomena”. The department of Laboratory Medicine & Pathobiology (LMP) at the Temerty Faculty of Medicine, University of Toronto is home to world-class research in the area of pathobiology, from cancer to immunopathology to neuropathology. The conference began with opening remarks from LMPSU executives Karen Mao and Ziqi Liu, followed by Dr. Rita Kandel, the chair of the department of LMP. The topic of COVID-19 research was timely, to say the least! Invited speakers were asked to share their research and knowledge about various aspects of the COVID-19 pandemic from basic virology to treatment options, and epidemiology. The keynote speakers were Dr. Samira Mubareka and Dr. Robert Kozak; notably members of the team that was among the first to isolate the SARS-CoV-2 virus.
Highlights
On January 9th, 2021, the Laboratory Medicine & Pathobiology Students Union (LMPSU) hosted their annual scientific conference online, focusing on the theme: “COVID-19: A viral phenomena”.The department of Laboratory Medicine & Pathobiology (LMP) at the Temerty Faculty of Medicine, University of Toronto is home to world-class research in the area of pathobiology, from cancer to immunopathology to neuropathology
The conference began with opening remarks from LMPSU executives Karen Mao and Ziqi Liu, followed by Dr Rita Kandel, the chair of the department of LMP
Dr Mubareka began her talk by discussing her work concerning the genome sequencing of SARS-CoV-2. Her team has sequenced over 800 genomes from patient viral samples and uploaded much of the data to GISAID, a global platform for sharing data related to COVID-19
Summary
On January 9th, 2021, the Laboratory Medicine & Pathobiology Students Union (LMPSU) hosted their annual scientific conference online, focusing on the theme: “COVID-19: A viral phenomena”. Dr Mubareka began her talk by discussing her work concerning the genome sequencing of SARS-CoV-2 Her team has sequenced over 800 genomes from patient viral samples and uploaded much of the data to GISAID, a global platform for sharing data related to COVID-19. This form of scientific collaboration is essential explains Dr Mubareka, because much of the genomic research on SARS-CoV-2 requires large data sets and from a diverse population in order to be able to draw meaningful conclusions. In his talk, Dr Kozak specified the pandemic research priorities: diagnostic methods, treatments, and vaccines.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
